Showing results (171-180 of 229) with videos related to
Sort By:
Pageof 23
Pain|March 1, 2005
Altered primary afferent anatomy and reduced thermal sensitivity in mice lacking galectin-1J McGraw, A D Gaudet, L W Oschipok, et al.The Pharmacogenomics Journal|November 30, 2005
(AAT)n repeat in the cannabinoid receptor gene (CNR1): association with cocaine addiction in an African-Caribbean populationN Ballon, S Leroy, C Roy, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 28, 2000
Evolution of plasma homovanillic acid (HVA) levels during treatment in schizo-affective disorderA Galinowski, C Castelnau, O Spreux-Varoquaux, et al.L'Encephale|March 1, 1995
[Social adjustment and depression: value of the SAS-SR (Social Adjustment Scale Self-Report)]S Achard, J M Chignon, M F Poirier-Littré, et al.Neuroreport|March 10, 2001
Impairment of predictive saccades in schizophreniaM O Krebs, A Gut-Fayand, I Amado, et al.Journal of Virology|August 1, 1987
Rous sarcoma virus mutant dlPA105 induces different transformed phenotypes in quail embryonic fibroblasts and neuroretina cellsF Poirier, D Laugier, M Marx, et al.The Journal of Laboratory and Clinical Medicine|November 1, 1990
Conjugated catecholamines in human plasma: where are they coming from?J L Cuche, P Brochier, N Klioua, et al.Presse Medicale (Paris, France : 1983)|June 22, 1985
[Study of the metabolism of cerebral noradrenaline in depressed patients by the assay of plasma dihydroxyphenylethylene glycol]H Loo, B Scatton, M F Poirier, et al.American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 23, 2003
5HTTLPR polymorphism in schizophrenic patients: further support for association with violent suicide attemptsF J Bayle, S Leroy, D Gourion, et al.Psychopharmacology|March 1, 1996
In vivo characteristics of dopamine D2 receptor occupancy by amisulpride in schizophreniaJ L Martinot, M L Paillère-Martinot, M F Poirier, et al.Pageof 23